220 related articles for article (PubMed ID: 6725657)
1. Topical therapy of alopecia areata with squaric acid dibutylester.
Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
[TBL] [Abstract][Full Text] [Related]
2. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
3. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
4. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
Orecchia G; Malagoli P; Santagostino L
Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
8. Treatment of alopecia areata with squaric acid dibutylester.
Caserio RJ
Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
[TBL] [Abstract][Full Text] [Related]
9. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
van der Steen PH; Boezeman JB; Happle R
Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
[TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
11. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
Valsecchi R; Pansera B; Rossi A; Cainelli T
G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
Tosti A; Guidetti MS; Bardazzi F; Misciali C
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020
[TBL] [Abstract][Full Text] [Related]
13. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
Vedak P; Kroshinsky D
J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
[TBL] [Abstract][Full Text] [Related]
14. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
15. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
Losol E; Şentürk N
Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
[TBL] [Abstract][Full Text] [Related]
16. Modified immunotherapy for alopecia areata.
Yoshimasu T; Furukawa F
Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
[TBL] [Abstract][Full Text] [Related]
17. Alopecia areata: more on topical sensitizers.
Orecchia G; Marelli MA; Perfetti L; Rabbiosi G
Dermatologica; 1990; 180(2):57-9. PubMed ID: 2311796
[TBL] [Abstract][Full Text] [Related]
18. Topical squaric acid dibutylester therapy for alopecia areata.
Flowers FP; Slazinski L; Fenske NA; Pullara TJ
Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
[No Abstract] [Full Text] [Related]
19. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
Starace M; Vezzoni R; Alessandrini A; Bruni F; Carpanese MA; Misciali C; Sechi A; Piraccini BM
Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
[TBL] [Abstract][Full Text] [Related]
20. Treatment of alopecia areata with squaric acid dibutylester.
Micali G; Cicero RL; Nasca MR; Sapuppo A
Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]